3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
Rituximab
5
Valganciclovir
2
Methotrexate
2
Leucovorin
2
Doxorubicin
2
valomaciclovir
1
threonic acid
1
pembrolizumab
1
otelixizumab
1
merphos
1
cc-486
1
avelumab
1
Zidovudine
1
Vincristine
1
Valacyclovir
1
Tomography, X-Ray Computed
1
Prednisone
1
Magnesium Sulfate
1
Interferons
1
Hydroxyurea
1
Etoposide
1
Echocardiography
1
EPOCH protocol
1
Cyclophosphamide
1
Caves
1
Carboplatin
1
Brentuximab Vedotin
1
Bortezomib
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Epstein-Barr Virus Infections
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.